OTCPK:IVME

Stock Analysis Report

In Veritas Medical Diagnostics

Executive Summary

In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • In Veritas Medical Diagnostics's last earnings update was 4207 days ago.
  • In Veritas Medical Diagnostics is not covered by any analysts.

Share Price & News

How has In Veritas Medical Diagnostics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

IVME

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

n/a

IVME

9.9%

US Medical Equipment

1.6%

US Market

No trading data on IVME.

No trading data on IVME.


Share holder returns

IVMEIndustryMarket
7 Day0%0.5%-0.02%
30 Day-12.5%0.09%2.7%
90 Day-6.7%2.0%1.4%
1 Yearn/a10.8%9.9%3.8%1.6%
3 Yearn/a69.0%63.9%45.2%35.8%
5 Year-46.2%-46.2%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is In Veritas Medical Diagnostics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is In Veritas Medical Diagnostics undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether In Veritas Medical Diagnostics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as In Veritas Medical Diagnostics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine In Veritas Medical Diagnostics's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through In Veritas Medical Diagnostics regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is In Veritas Medical Diagnostics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as In Veritas Medical Diagnostics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has In Veritas Medical Diagnostics performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, In Veritas Medical Diagnostics has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is In Veritas Medical Diagnostics's financial position?


In this section we usually analyse In Veritas Medical Diagnostics's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. In Veritas Medical Diagnostics has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of IVME’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when In Veritas Medical Diagnostics's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is In Veritas Medical Diagnostics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate In Veritas Medical Diagnostics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate In Veritas Medical Diagnostics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as In Veritas Medical Diagnostics has not reported any payouts.

Unable to verify if In Veritas Medical Diagnostics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as In Veritas Medical Diagnostics has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of In Veritas Medical Diagnostics's salary, the management and board of directors tenure and is there insider trading?

13.3yrs

Average management tenure


CEO

G. Cooper (72yo)

13.3yrs

Tenure

US$116,471

Compensation

Mr. Graham Cooper has been Chairman of In Veritas Medical Diagnostics Inc. since January 2000 and also its President and Chief Executive Officer since June 20, 2006. Mr. Cooper is the founder and serves as ...


Management Age and Tenure

13.3yrs

Average Tenure

The average tenure for the In Veritas Medical Diagnostics management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

18.2yrs

Average Tenure

67yo

Average Age

The average tenure for the In Veritas Medical Diagnostics board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Martin Thorp (67yo)

    CFO, Principal Accounting Officer & Director

    • Tenure: 14.4yrs
    • Compensation: US$689.74k
  • G. Cooper (72yo)

    Chairman

    • Tenure: 13.3yrs
    • Compensation: US$116.47k
  • Trish Connolly

    Director of Science & Operations

    • Tenure: 0yrs
  • Robert Galvin

    Head of Administration & Financial Controller

    • Tenure: 12.9yrs

Board Members

  • Martin Thorp (67yo)

    CFO, Principal Accounting Officer & Director

    • Tenure: 14.4yrs
    • Compensation: US$689.74k
  • G. Cooper (72yo)

    Chairman

    • Tenure: 13.3yrs
    • Compensation: US$116.47k
  • John Fuller (57yo)

    Non Executive Director

    • Tenure: 18.2yrs
    • Compensation: US$179.86k

Company Information

In Veritas Medical Diagnostics, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: In Veritas Medical Diagnostics, Inc.
  • Ticker: IVME
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$42.254k
  • Shares outstanding: 60.36m
  • Website: https://null

Location

  • In Veritas Medical Diagnostics, Inc.
  • The Green House
  • Beechwood Business Park North
  • Inverness
  • Inverness-shire
  • IV2 3Bl
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IVMEOTCPK (Pink Sheets LLC)YesCommon StockUSUSDMay 2004

Biography

In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrom ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 00:44
End of Day Share Price2019/09/18 00:00
Earnings2008/01/31
Annual Earnings2007/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.